Bristol-Myers CEO Giovanni Caforio Nets $18.7M in 2017 Pay, a 10% Raise

As Bristol-Myers Squibb presses ahead in oncology and after a big finish in the fourth quarter, CEO Giovanni Caforio is taking home a 10% pay raise for 2017 to $18.7 million. His stepped-up compensation followed a year in which Bristol-Myers exceeded the CEO's overall revenue target—and beat individual sales targets for a list of key drugs...
Login to comment.